• Investment Books

  
  

• Smart Investment

  

Aurobindo Pharma gets USFDA approval

Hyderabad-based, Aurobindo Pharma has received the approval for its chewable and dispersible Lamotrigine tablets from the US Food & Drug Administration (USFDA).

With this latest approval, the pharma major has a total of 107 approvals from USFDA in its kitty.

Lamotrigine tablets 5mg and 25mg is generic equivalent to Lamictal CD tablets 5 mg and 25 mg of GlaxoSmithKline, the compay said in a statement today. It falls under the central nervous system (CNS) segment and is indicated as adjunctive therapy for partial seizures and generalised seizures of Lennox-Gastaut syndrome in patients aged 2 years and older.

-Business Standerd.

Tags:adjunctive therapy, Aurobindo, Aurobindo Pharma, central nervous system, CNS, generalised seizures, kitty, Lamotrigine tablets, Lennox-Gastaut, pharma, segment, syndrome, US Food & Drug Administration, USFDA, USFDA Approval

Related Post :

• Aurobindo gets USFDA nod for Sumatriptan Succinate tablets
• Aurobindo Pharma gets USFDA nod for Zidovudine tablets
• Alembic gets USFDA nod for Metronidazole capsule
• Dr Reddy`s US arm obtains USFDA nod
• Sun Pharma gets USFDA approval for Oxycodone HCL
• Aurobindo Pharma gets approval for Finasteride Tablets
• Aurobindo gets approval from Swissmedic for BPH drug
• Aurobindo Pharma promoter pledges 28.12 pc stake

• Search

• Investment Books

  
  

• Smart Investment